NCT06923397 2025-12-16Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND TrialDana-Farber Cancer InstitutePhase NA Recruiting24 enrolled